Telomeres, telomerase, and myc. An update
- PMID: 10648922
- DOI: 10.1016/s1383-5742(99)00091-5
Telomeres, telomerase, and myc. An update
Abstract
Normal human somatic cells have a finite life span in vivo as well as in vitro and retire into senescence after a predictable time. Cellular senescence is triggered by the activation of two interdependent mechanisms. One induces irreversible cell cycle exit involving activation of two tumorsuppressor genes, p53 and pRb, and the proper time point is indicated by a critical shortening of chromosomal ends due to the end-replication problem of DNA synthesis. The development of a malignant cancer cell is only possible when both mechanisms are circumvented. The majority of human cancers and tumor cell lines produce telomerase, a ribonucleoprotein with two components required for core enzyme activity: telomerase RNA (TR) and a telomerase reverse transcriptase protein (TERT). Telomerase adds hexameric DNA repeats (TTAGGG) to telomeric ends and thus compensates the progressive loss of telomeric sequences inherent to DNA replication. While TR of telomerase is present in almost all human cells, human TERT (hTERT) was found rate limiting for telomerase activity. Ectopic expression of hTERT in otherwise mortal human cells induced efficient elongation of telomeres and permanent cell growth. While hTERT-mediated immortalization seems to have no effect on growth potential and cell cycle check points, it bestows an increased susceptibility to experimental transformation. One oncogene that might activate TERT in the natural context is c-myc. Myc genes are frequently deregulated in human tumors and myc overexpression may cause telomerase reactivation and telomere stabilization which, in turn, would allow permanent proliferation. Is this a general strategy of incipient cancer cells to escape senescence? Several recent observations indicate that other scenarios may be conceived as well.
Similar articles
-
Telomerase activation, cellular immortalization and cancer.Ann Med. 2001 Mar;33(2):123-9. doi: 10.3109/07853890109002067. Ann Med. 2001. PMID: 11327115 Review.
-
Telomere length maintenance in aging and carcinogenesis.Int J Oncol. 2000 Nov;17(5):981-9. doi: 10.3892/ijo.17.5.981. Int J Oncol. 2000. PMID: 11029502 Review.
-
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5024-33. doi: 10.1073/pnas.1602379113. Epub 2016 Aug 8. Proc Natl Acad Sci U S A. 2016. PMID: 27503890 Free PMC article.
-
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.Curr Biol. 1998 Feb 26;8(5):279-82. doi: 10.1016/s0960-9822(98)70109-5. Curr Biol. 1998. PMID: 9501072
-
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8. doi: 10.1073/pnas.95.25.14723. Proc Natl Acad Sci U S A. 1998. PMID: 9843956 Free PMC article.
Cited by
-
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer.J Carcinog. 2005 Oct 4;4:17. doi: 10.1186/1477-3163-4-17. J Carcinog. 2005. PMID: 16202165 Free PMC article.
-
BRCA1 inhibition of telomerase activity in cultured cells.Mol Cell Biol. 2003 Dec;23(23):8668-90. doi: 10.1128/MCB.23.23.8668-8690.2003. Mol Cell Biol. 2003. PMID: 14612409 Free PMC article.
-
Biophysical characterization of an ensemble of intramolecular i-motifs formed by the human c-MYC NHE III1 P1 promoter mutant sequence.Biophys J. 2010 Jul 21;99(2):561-7. doi: 10.1016/j.bpj.2010.04.042. Biophys J. 2010. PMID: 20643075 Free PMC article.
-
Impaired telomerase activity hinders proliferation and in vitro transformation of Penaeus monodon lymphoid cells.Cytotechnology. 2016 Aug;68(4):1301-14. doi: 10.1007/s10616-015-9890-9. Epub 2015 Jun 18. Cytotechnology. 2016. PMID: 26084784 Free PMC article.
-
Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.Cytotechnology. 2018 Aug;70(4):1143-1154. doi: 10.1007/s10616-018-0205-9. Epub 2018 Mar 15. Cytotechnology. 2018. PMID: 29546682 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous